May 12, 2006—Patients’ rights groups in India are suing Gilead Sciences to prevent the company from patenting HIV med tenofovir (branded Viread in the U.S.). A local patent would force Indian companies to stop producing a generic version sold inexpensively to Indians and to developing countries worldwide.